Literature DB >> 6839161

Dopaminergic and non-dopaminergic projections to amygdala from substantia nigra and ventral tegmental area.

S E Loughlin, J H Fallon.   

Abstract

The projections from the substantia nigra (SN) and ventral tegmental area (VTA) to the amygdala of the rat were examined by simultaneous visualization of catecholamine (CA) histofluorescence and retrograde tracer. CA-containing cells in lateral VTA, medial SN and the dorsal edge of SN pars compacta were labeled by injections of propidium iodide (PI) into the amygdala. While CA-containing cells were present in SN pars lateralis (SNl), those cells which were labeled by injections into the amygdala did not contain CA. There is, thus, a significant non-DA projection from SNl to the amygdala.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6839161     DOI： 10.1016/0006-8993(83)91029-6

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


  19 in total

1.  Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo.

Authors:  J A Rosenkranz; A A Grace
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Relative contributions and mapping of ventral tegmental area dopamine and GABA neurons by projection target in the rat.

Authors:  Jocelyn M Breton; Annabelle R Charbit; Benjamin J Snyder; Peter T K Fong; Elayne V Dias; Patricia Himmels; Hagar Lock; Elyssa B Margolis
Journal:  J Comp Neurol       Date:  2018-12-11       Impact factor: 3.215

3.  The Cerebellar GABAAR System as a Potential Target for Treating Alcohol Use Disorder.

Authors:  David J Rossi; Ben D Richardson
Journal:  Handb Exp Pharmacol       Date:  2018

4.  Basolateral amygdala responds robustly to social calls: spiking characteristics of single unit activity.

Authors:  Robert T Naumann; Jagmeet S Kanwal
Journal:  J Neurophysiol       Date:  2011-03-02       Impact factor: 2.714

Review 5.  Dopamine: Functions, Signaling, and Association with Neurological Diseases.

Authors:  Marianne O Klein; Daniella S Battagello; Ariel R Cardoso; David N Hauser; Jackson C Bittencourt; Ricardo G Correa
Journal:  Cell Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.046

6.  Dopamine receptor mechanisms mediate corticotropin-releasing factor-induced long-term potentiation in the rat amygdala following cocaine withdrawal.

Authors:  Balaji Krishnan; Marjorie Centeno; Sebastian Pollandt; Yu Fu; Kathy Genzer; Jie Liu; Joel P Gallagher; Patricia Shinnick-Gallagher
Journal:  Eur J Neurosci       Date:  2010-03-08       Impact factor: 3.386

7.  Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons.

Authors:  Hui-Ling Wang; Marisela Morales
Journal:  J Comp Neurol       Date:  2008-07-20       Impact factor: 3.215

8.  Blockade of the acquisition, but not expression, of associative learning by pre-session intra-amygdala R(+) 7-OH-DPAT.

Authors:  Gavin D Phillips; Paul K Hitchcott
Journal:  Psychopharmacology (Berl)       Date:  2008-10-24       Impact factor: 4.530

Review 9.  Cortico-Basal Ganglia reward network: microcircuitry.

Authors:  Susan R Sesack; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 10.  An update on the connections of the ventral mesencephalic dopaminergic complex.

Authors:  L Yetnikoff; H N Lavezzi; R A Reichard; D S Zahm
Journal:  Neuroscience       Date:  2014-04-13       Impact factor: 3.590
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.